Visit Diabetes News from dLife.com

Candesartan can increase regression of retinopathy in type 2 diabetes

Posted on September 25, 2008

September 25, 2008 (EurekAlert) - Treatment with candesartan can increase regression of retinopathy in type 2 diabetes and reduce incidence of retinopathy in type 1 diabetes. These are among the conclusions of the DIRECT studies, published early Online and in an upcoming edition of The Lancet. Diabetic retinopathy is a leading cause of blindness in people of working age. In the first of the two Articles, Professor Nish Chaturvedi, National Heart and Lung Institute, Imperial College Healthcare NHS Trust, London, UK, and colleagues, examine the effect of candesartan on incidence and progr...

Original article link


diabetes , lung , type 1 diabetes , type 2 diabetes